Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series
Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
Taylor & Francis Group
2019-06-01
|
| シリーズ: | CNS Oncology |
| 主題: | |
| オンライン･アクセス: | https://www.futuremedicine.com/doi/10.2217/cns-2019-0007 |